| Trial ID: | L4480 |
| Source ID: | NCT01397513
|
| Associated Drug: |
Aspirin
|
| Title: |
Effects of Aspirin Treatment on Fibrin Network Formation in Patients With Type 1 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 1
|
| Interventions: |
DRUG: Aspirin
|
| Outcome Measures: |
Primary: Fibrin network permeability, Changes in fibrin network permeability after 4 weeks of treatment with either aspirin 75 or 320mg., At the start and end of each 4-week treatment period | Secondary: Fibrin network permeability, Subgroup analyses comparing the treatment effects of aspirin 75 or 320mg on fibrin network permeability in patients with good and poor glycemic control, respectively., At the start and end of each 4-week treatment period|Platelet microparticles, Changes in plasma concentrations of platelet microparticles after 4 weeks of treatment with either aspirin 75 or 320mg., At the start and end of each 4-week treatment period
|
| Sponsor/Collaborators: |
Sponsor: Karolinska Institutet
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
48
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-03
|
| Completion Date: |
2011-02
|
| Results First Posted: |
|
| Last Update Posted: |
2011-07-19
|
| Locations: |
Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Stockholm, 18288, Sweden
|
| URL: |
https://clinicaltrials.gov/show/NCT01397513
|
